Schedule 13G ownership disclosure

Contineum Therapeutics Inc

Class A Common Stock, $0.001 par value per share · CUSIP: 21217B100

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.

    Shares: 2,179,711.00 · Class: 7.2%

  • Peter Kolchinsky

    Shares: 2,179,711.00 · Class: 7.2%

  • Rajeev Shah

    Shares: 2,179,711.00 · Class: 7.2%

  • RA Capital Healthcare Fund, L.P.

    Shares: 2,179,711.00 · Class: 7.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001346824-26-000037
Form type
SCHEDULE 13G/A
Filer
Contineum Therapeutics, Inc.
CIK
CIK 1855175
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub